Stereotaxis, Inc. (STXS)

Market Cap	265.93M
Revenue (ttm)	31.81M
Net Income (ttm)	-24.64M
Shares Out	91.07M
EPS (ttm)	-0.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200,423
Open	2.900
Previous Close	2.920
Day's Range	2.900 - 2.980
52-Week Range	1.540 - 3.590
Beta	1.65
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2025

About STXS

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminat...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Aug 12, 2004
• Employees: 139
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: STXS
• Website: https://www.stereotaxis.com

Financial Performance

In 2024, Stereotaxis's revenue was $26.92 million, an increase of 0.55% compared to the previous year's $26.77 million. Losses were -$25.35 million, 14.9% more than in 2023.